tirzepatide dumping syndrome Rapid Gastric Emptying Dumping Syndrome Diagram Tirzepatide Mounjaro Slows Gastric Emptying

What we like about a two product, targeted approach is that it attempts to address both directions of the GLP-1 pathway: Direct activation of L cells and receptor signalling Indirect support through the gut microbiome and metabolic environment That means we are not just telling the body to release more GLP-1, but also creating the conditions for GLP-1 to be more effective and longer lasting

Its not a loophole

The authors found that patients on GLP-1RAs had a significantly lower risk of developing pancreatic cancer compared to those on insulin (hazard ratio [HR]: 0.56), DPP-4 inhibitors (HR: 0.80), SGLT2 inhibitors (HR: 0.78), and sulfonylureas (HR: 0.84)

Studies have shown that the expression of inflammatory markers such as Tumor Necrosis Factor alpha (TNF-a) and Interleukin-6 (IL-6) significantly diminish when there are high cellular levels of NAD+ and its precursors

: Li J, Liu L, Weng J, Yin TL, Yang J, Feng HL